Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 112

1.

The diagnostic efficiency of biomarkers in sporadic Creutzfeldt-Jakob disease compared to Alzheimer's disease.

Bahl JM, Heegaard NH, Falkenhorst G, Laursen H, Høgenhaven H, Mølbak K, Jespersgaard C, Hougs L, Waldemar G, Johannsen P, Christiansen M.

Neurobiol Aging. 2009 Nov;30(11):1834-41. doi: 10.1016/j.neurobiolaging.2008.01.013. Epub 2008 Mar 12.

PMID:
18339451
2.

Diagnostic value of CSF protein profile in a Portuguese population of sCJD patients.

Baldeiras IE, Ribeiro MH, Pacheco P, Machado A, Santana I, Cunha L, Oliveira CR.

J Neurol. 2009 Sep;256(9):1540-50. doi: 10.1007/s00415-009-5160-0. Epub 2009 May 6.

PMID:
19418113
3.

The role of cerebrospinal fluid 14-3-3 and other proteins in the diagnosis of sporadic Creutzfeldt-Jakob disease in the UK: a 10-year review.

Chohan G, Pennington C, Mackenzie JM, Andrews M, Everington D, Will RG, Knight RS, Green AJ.

J Neurol Neurosurg Psychiatry. 2010 Nov;81(11):1243-8. doi: 10.1136/jnnp.2009.197962. Epub 2010 Sep 20.

PMID:
20855493
4.

Cerebrospinal fluid markers in sporadic Creutzfeldt-Jakob disease.

Zanusso G, Fiorini M, Ferrari S, Gajofatto A, Cagnin A, Galassi A, Richelli S, Monaco S.

Int J Mol Sci. 2011;12(9):6281-92. doi: 10.3390/ijms12096281. Epub 2011 Sep 23.

5.

CSF Tau proteins reduce misdiagnosis of sporadic Creutzfeldt-Jakob disease suspected cases with inconclusive 14-3-3 result.

Leitão MJ, Baldeiras I, Almeida MR, Ribeiro MH, Santos AC, Ribeiro M, Tomás J, Rocha S, Santana I, Oliveira CR.

J Neurol. 2016 Sep;263(9):1847-61. doi: 10.1007/s00415-016-8209-x. Epub 2016 Jun 29.

PMID:
27357003
6.

Sporadic Creutzfeldt-Jakob disease diagnostic accuracy is improved by a new CSF ELISA 14-3-3γ assay.

Leitão MJ, Baldeiras I, Almeida MR, Ribeiro MH, Santos AC, Ribeiro M, Tomás J, Rocha S, Santana I, Oliveira CR.

Neuroscience. 2016 May 13;322:398-407. doi: 10.1016/j.neuroscience.2016.02.057. Epub 2016 Mar 3.

PMID:
26940479
7.

Subtype and regional regulation of prion biomarkers in sporadic Creutzfeldt-Jakob disease.

Llorens F, Zafar S, Ansoleaga B, Shafiq M, Blanco R, Carmona M, Grau-Rivera O, Nos C, Gelpí E, Del Río JA, Zerr I, Ferrer I.

Neuropathol Appl Neurobiol. 2015 Aug;41(5):631-45. doi: 10.1111/nan.12175. Epub 2015 Apr 30.

PMID:
25134744
8.

Influence of timing on CSF tests value for Creutzfeldt-Jakob disease diagnosis.

Sanchez-Juan P, Sánchez-Valle R, Green A, Ladogana A, Cuadrado-Corrales N, Mitrová E, Stoeck K, Sklaviadis T, Kulczycki J, Hess K, Krasnianski A, Equestre M, Slivarichová D, Saiz A, Calero M, Pocchiari M, Knight R, van Duijn CM, Zerr I.

J Neurol. 2007 Jul;254(7):901-6. Epub 2007 Mar 25.

9.

Tau and 14-3-3 of genetic and sporadic Creutzfeldt-Jakob disease patients in Israel.

Meiner Z, Kahana E, Baitcher F, Korczyn AD, Chapman J, Cohen OS, Milo R, Aharon-Perez J, Abramsky O, Gabizon R, Rosenmann H.

J Neurol. 2011 Feb;258(2):255-62. doi: 10.1007/s00415-010-5738-6. Epub 2010 Sep 9.

PMID:
20827556
10.

Diagnostic accuracy of cerebrospinal fluid protein markers for sporadic Creutzfeldt-Jakob disease in Canada: a 6-year prospective study.

Coulthart MB, Jansen GH, Olsen E, Godal DL, Connolly T, Choi BC, Wang Z, Cashman NR.

BMC Neurol. 2011 Oct 27;11:133. doi: 10.1186/1471-2377-11-133.

11.

The role of cerebrospinal fluid proteins as early diagnostic markers for sporadic Creutzfeldt-Jakob disease.

Pennington C, Chohan G, Mackenzie J, Andrews M, Will R, Knight R, Green A.

Neurosci Lett. 2009 May 8;455(1):56-9. doi: 10.1016/j.neulet.2009.02.067. Epub 2009 Mar 5.

PMID:
19429106
12.

Desmoplakin as a potential candidate for cerebrospinal fluid marker to rule out 14-3-3 false positive rates in sporadic Creutzfeldt-Jakob disease differential diagnosis.

Gawinecka J, Ciesielczyk B, Sanchez-Juan P, Schmitz M, Heinemann U, Zerr I.

Neurodegener Dis. 2012;9(3):139-44. doi: 10.1159/000334499. Epub 2011 Dec 31.

PMID:
22213780
13.

Association of cerebrospinal fluid prion protein levels and the distinction between Alzheimer disease and Creutzfeldt-Jakob disease.

Dorey A, Tholance Y, Vighetto A, Perret-Liaudet A, Lachman I, Krolak-Salmon P, Wagner U, Struyfs H, De Deyn PP, El-Moualij B, Zorzi W, Meyronet D, Streichenberger N, Engelborghs S, Kovacs GG, Quadrio I.

JAMA Neurol. 2015 Mar;72(3):267-75. doi: 10.1001/jamaneurol.2014.4068.

PMID:
25559883
14.

Total tau protein in cerebrospinal fluid and diffusion-weighted MRI as an early diagnostic marker for Creutzfeldt-Jakob disease.

Satoh K, Shirabe S, Tsujino A, Eguchi H, Motomura M, Honda H, Tomita I, Satoh A, Tsujihata M, Matsuo H, Nakagawa M, Eguchi K.

Dement Geriatr Cogn Disord. 2007;24(3):207-12. Epub 2007 Aug 10.

PMID:
17690553
15.

Cerebrospinal fluid tau levels are a marker for molecular subtype in sporadic Creutzfeldt-Jakob disease.

Karch A, Hermann P, Ponto C, Schmitz M, Arora A, Zafar S, Llorens F, Müller-Heine A, Zerr I.

Neurobiol Aging. 2015 May;36(5):1964-8. doi: 10.1016/j.neurobiolaging.2015.01.021. Epub 2015 Feb 7.

PMID:
25749129
16.

Cerebrospinal fluid biomarkers in Creutzfeldt-Jakob disease.

Van Everbroeck B, Boons J, Cras P.

Clin Neurol Neurosurg. 2005 Aug;107(5):355-60. Epub 2005 Jan 12. Review.

PMID:
16023527
17.

Raised CSF phospho-tau concentrations in variant Creutzfeldt-Jakob disease: diagnostic and pathological implications.

Goodall CA, Head MW, Everington D, Ironside JW, Knight RS, Green AJ.

J Neurol Neurosurg Psychiatry. 2006 Jan;77(1):89-91.

18.

Decreased CSF transferrin in sCJD: a potential pre-mortem diagnostic test for prion disorders.

Singh A, Beveridge AJ, Singh N.

PLoS One. 2011 Mar 9;6(3):e16804. doi: 10.1371/journal.pone.0016804.

19.

Diagnostic performance of cerebrospinal fluid total tau and phosphorylated tau in Creutzfeldt-Jakob disease: results from the Swedish Mortality Registry.

Skillbäck T, Rosén C, Asztely F, Mattsson N, Blennow K, Zetterberg H.

JAMA Neurol. 2014 Apr;71(4):476-83. doi: 10.1001/jamaneurol.2013.6455.

PMID:
24566866
20.

CSF neurofilament proteins levels are elevated in sporadic Creutzfeldt-Jakob disease.

van Eijk JJ, van Everbroeck B, Abdo WF, Kremer BP, Verbeek MM.

J Alzheimers Dis. 2010;21(2):569-76. doi: 10.3233/JAD-2010-090649.

PMID:
20555148

Supplemental Content

Support Center